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Review
On the Origin of Species: Factors Shaping the Establishment
of Infant’s Gut Microbiota
Niels van Best1,2, Mathias W. Hornef1, Paul H. M. Savelkoul2,3,4, and John Penders*2,4
The human gut microbiota is a complex and dynamic ecosystem, which
naturally lives in a symbiotic relationship with the host. Perturbations of the
microbial composition (dysbiosis) and reduced diversity may promote disease
susceptibility and recurrence. In contrast to the mature intestinal microbiota
of healthy adults, which appears relatively stable over time, the infant’s
microbiome only establishes and matures during the first years of life. In this
respect, early childhood seems to represent a crucial age-window in disease
prevention, since microbial diversification and maturation of the microbiome
primarily occurs during this period of life. A better understanding of ecological
processes and pioneer consortia in microbial development is crucial, in order
to support the development of a beneficial microbiota. Various deterministic
and stochastic aspects seem to shape the microbiome in early life, including
maternal, environmental, and host factors. Here, we review the current
understanding of the origin of pioneer bacteria and the evolutionary factors
that influence the development of the gut microbiota in infants. In addition,
future perspectives, including manipulating and promoting the succession of
initial bacteria during infancy, will be highlighted.
Birth Defects Research (Part C) 105:240–251, 2015.
VC 2015 Wiley Periodicals, Inc.
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Introduction
The human gut microbiota is a complex and dynamic eco-
system consisting of hundreds to thousands of distinct
bacterial species, as well as microbial eukaryotes, viruses,
phages, and a limited number of Archaea, which naturally
live in a symbiotic relationship with the host (Hooper and
Gordon, 2001). In the past decades, the knowledge on the
role of the gut microbiota and its development, as well as
host-microbial interactions in human health and disease,
has rapidly increased due to the advancement of modern
molecular technologies. On one hand, the microbiota has a
profound impact on its host by providing a competitive
barrier against invading pathogens, utilizing undigested
food components and producing essential metabolites,
modulating immune responses, and stimulating intestinal
maturation (Macpherson and Harris, 2004; Turnbaugh
et al., 2007). On the other hand, the host’s immune system
needs to tolerate the lumenal microbiota, but avoid their
overgrowth and translocation of bacteria into the subepi-
thelial tissue. As such, a perturbation of the microbial
communities (dysbiosis) has the ability to promote disease
susceptibility and progression. Indeed, alterations in
microbiota composition and function have been associated
with many diseases, including metabolic diseases (i.e. obe-
sity, non-alcoholic fatty liver disease) (Turnbaugh et al.,
2006; van Best et al., 2015) and immune-related diseases
(i.e., inflammatory bowel disease, allergies) (Penders et al.,
2007; Erickson et al., 2012; Rajilic-Stojanovic et al., 2015).
Moreover, dysbiosis has also been linked to neoplastic dis-
eases (Petra et al., 2014), mental disorders, and autism-
spectrum disorder (Mayer et al., 2015), although it has to
be noted that for many of these diseases causality has still
to be proven. The prevalence of many of these inflamma-
tory noncommunicable diseases (NCDs) has increased rap-
idly over the past few decades, especially in western
countries. As such, microbiota perturbations as a conse-
quence of modern lifestyle are often held (in part)
accountable for the rise in prevalence of NCD’s (West
et al., 2015).
Our knowledge on the intestinal microbial ecophysiology
and the processes contributing to microbial dysbiosis has a
direct impact on our ability to manage and maintain human
health. In this respect, early childhood appears to be a cru-
cial age-window, since diversification and maturation of the
microbiota primarily occurs during this period of life. In
contrast to the mature intestinal microbiota of healthy
adults, which seems to be relatively stable over time, the
infant microbiota waxes and wanes as diet changes and the
host develops. Longitudinal studies monitoring the dynamics
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of the newborn microbiota (Favier et al., 2002; Palmer et al.,
2007; Koenig et al., 2011) showed that periods of relative
stability were interrupted by abrupt changes in microbial
community structure and diversity. In some, but not all
cases, these changes can be linked to preceding life events
(e.g., weaning, fever, medication), indicating that both deter-
ministic and stochastic aspects shape the microbiota in early
life.
Here, we review the origin of pioneer bacteria and evo-
lutionary factors that influence the development of the gut
microbiota in infants. In addition, the potential of manipu-
lating the microbiota for prevention and treatment of dis-
orders in early life will be discussed.
Factors Influencing the Intestinal Microbiota
Development
MATERNAL EXPOSURE
In utero transmission. Until recently, the initial microbial colo-
nizers of the neonatal intestine were supposed to originate
from the maternal perineal, vaginal, and fecal microbiota.
However, the development of the microbiota composition
might already start before birth by microbial transfer
through the placental barrier. Recent sequencing studies
revealed the presence of DNA derived from a wide variety
of microbial taxa in the human placenta, umbilical cord
blood, amniotic fluid, and meconium (Jimenez et al., 2008;
DiGiulio, 2012; Funkhouser and Bordenstein, 2013;
Aagaard et al., 2014). Although the presence of bacteria,
such as Mycoplasma and Ureaplasma, have long been
implicated in invasion of the amniotic cavity and detrimen-
tal health effects, such as preterm birth and necrotizing
enterocolitis (Goldenberg and Culhane, 2003; Okogbule-
Wonodi et al., 2011; DiGiulio, 2012), these recent findings
suggest that normal colonization may already start before
rupture of membranes and birth. The placental microbiota
has been suggested to resemble the oral microbiota from
the Firmicutes, Tenericutes, Proteobacteria, Bacteroidetes,
and Fusobacteria phyla, indicating a possible mode of bac-
terial transmission to the fetus (Aagaard et al., 2014). This
evidence is, however, indirect as the investigators did not
compare the placental and oral microbiota of the same
subjects, but rather examined the oral microbiota in non-
pregnant individuals. An experimental animal study using
labeled Enterococcus faecium further evidenced that mater-
nal bacteria can be transferred to fetuses in utero via the
gastrointestinal tract (Jimenez et al., 2008). The underlying
mechanism for this bacterial translocation remains unclear,
but several possibilities have been proposed, i.e., via pene-
tration of dendritic cells through the gut epithelium (Funk-
houser and Bordenstein, 2013). Interestingly, bacterial
translocation of the intestinal mucosa seems to be highly
increased in pregnant mice, in comparison to non-
pregnant animals (Perez et al., 2007).
Moreover, a number of studies detected a low abun-
dant microbiota in the meconium of preterm and term
infants using culture as well as molecular methods (Jime-
nez et al., 2008; Ardissone et al., 2014), implying that the
neonatal gut may not be sterile at birth. Culture techni-
ques revealed that Staphylococcus and Enterococcus predo-
minated in the meconium (Jimenez et al., 2008). DNA-
based techniques confirmed the predominance of these
genera together with Enterobacteriaceae (Ardissone et al.,
2014). The source of meconial bacteria remains unidenti-
fied, but they might have an intrauterine origin and be
derived from swallowed amniotic fluid. The observation
that the major genera observed in meconium are similar
to those detected in amniotic fluid (DiGiulio, 2012) and
less related to the bacteria prevailing in the maternal oral
or vaginal microbiome, is supportive for an intrauterine
origin (Ardissone et al., 2014).
Although these studies indicate that the neonatal gut
might already become colonized with bacteria before birth,
the majority of studies relied on culture-independent tech-
niques, and therefore culture-based methods are ulti-
mately required to establish a prepartum microbiota. The
detected bacterial DNA sequences may originate from
dead bacteria or free bacterial DNA in amniotic fluid, pla-
centa, and meconium specimens. Moreover, not birth, i.e.,
transit through the birth canal, but rather rupture of the
membranes, exposes the fetus to the environment and
thus needs to be considered as a critical endpoint. Finally,
the actual origin of these bacteria or bacterial remnants
needs to be considered. Sampling of material from the
same pregnant women at multiple sites may help to
exclude local infection or sample contamination. Clearly,
further research is necessary to clarify whether the poten-
tial in utero bacterial transmission of a low abundant inoc-
ulum truly contributes to the development of a healthy
neonatal microbiome, immune maturation, and metabo-
lism, or merely reflects the vulnerability that pregnancy
inflicts to the maternal host.
Mode of delivery. The microbial colonization of the human
intestine has traditionally been assumed to begin at birth
and further develop during early life to a diverse and
mature adult microbiota. Within a couple of days after
birth, the neonatal intestine becomes rapidly colonized by
maternal and environmental bacteria, strongly affected by
the delivery mode (Penders et al., 2006; Dominguez-Bello
et al., 2010). Infants born vaginally (i.e., passing the birth
canal in intimate contact with the vaginal mucosa) display
a microbiota similar to that of the maternal vagina, while
infants delivered by cesarean (C-) section demonstrate a
microbiota mainly consisting of commensal skin bacteria
(Dominguez-Bello et al., 2010). Accordingly, the initial
microbiota in vaginally delivered newborns is determined
by the vaginal milieu of the mother, which is predominated
by Lactobacillus, as well as by a high abundance of Prevo-
tella and Sneathia spp. (Dominguez-Bello et al., 2010;
Romero et al., 2014; MacIntyre et al., 2015). Infants born
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by C-section seem to have, in general, delayed and
decreased colonization of Bifidobacterium spp. and Bacter-
oides spp. and increased rates of Clostridium difficile and
typical skin bacteria such as Staphyloccocus, Corynebacte-
rium, and Propionibacterium spp,. compared with vaginally
delivered infants (Penders et al., 2006; Dominguez-Bello
et al., 2010; Fallani et al., 2010; Azad et al., 2013a; Jakobs-
son et al., 2014; Backhed et al., 2015). Increased rates of C.
difficile may result from environmental exposure, since C.
difficile spores can be found widespread in the hospital set-
ting. Consistently, C. difficile has been shown to be more
prevalent in neonates delivered in the hospital, as com-
pared with those born at home. Moreover, the risk of colo-
nization by this bacterium increased with each additional
day of hospitalization (Penders et al., 2006). Lacking the
inoculum of the maternal microbiota, the hospital environ-
ment and staff may represent an important source of bacte-
ria colonizing the intestinal tract of C-section delivered
infants. Longitudinal studies showed that the delayed and
altered colonization pattern in C-section delivered infants
persisted at least to the age of one year (Jakobsson et al.,
2014; Backhed et al., 2015), and even after 7 years of age
minor differences could be detected (Salminen et al., 2004).
However, a potential functional impact on infant’s develop-
ment and wellbeing has not been examined. In addition,
Salminen et al. (2004) visualized specific bacteria by fluo-
rescent in situ hybridization (FISH), and therefore compre-
hensive data on a fully established microbiota in later
childhood in relation to the mode of delivery are still
lacking.
Given the profound impact of the mode of delivery on
the establishment of the neonatal microbiome and its
potential consequences, the continuously increasing C-
section rates in many parts of the world are worrisome.
Recent findings, based on the ecological association of
cesarean delivery rates and perinatal outcomes from 19
developed countries (Ye et al., 2014), corroborated previ-
ous suggestions of the World Health Organization (WHO)
expert panel that population-level C-section delivery rates
above 10 to 15% are hardly justified by medical reasoning.
Yet, during the past decades, C-section rates have rapidly
increased far above 10 to 15% in many countries, mainly
attributable to nonevidence-based indications, professional
convenience, maternal request, and overmedication of
child-birth (Robson et al., 2013). In many European coun-
tries, the United States, and the larger cities in China and
Australia, rates have risen up to above 30%, while rates as
high as 45% have been reported for Brazil (Gibbons et al.,
2010).
The increased risk of obesity (Kuhle et al., 2015) and
childhood asthma (Huang et al., 2014) in children born by
C-section has been attributed to an altered intestinal colo-
nization pattern in these children. Indeed, within the con-
text of two birth cohort studies, mode of delivery was
shown to strongly impact the infant microbiota and affect
the risk of allergies and asthma (Penders et al., 2014).
Moreover, the decreased abundance of Bifidobacterium and
higher numbers of S. aureus in the intestine during early
life has been associated with subsequent overweight and
obesity in childhood (Kalliom€aki et al., 2008), emphasizing
the critical role of the first exposure.
INFANT FEEDING
Breastfeeding plays both directly, by containing living bac-
teria, and indirectly, by providing prebiotic nutrients and
bioactive components, an important role in the establish-
ment of the neonatal microbiota. The first abundant bacte-
ria of the newborn’s gut are generally facultative
anaerobes, such as Escherichia, Streptococcus, and Entero-
coccus, probably due to the oxygen-rich environment in
the neonatal gut lumen (Avershina et al., 2014; Backhed
et al., 2015). Although some studies observed a gradual
shift in microbial composition and increase in diversity
(Koenig et al., 2011), other studies demonstrated chaotic
shifts over time, including a transient drop in diversity
within the first week of life (Yatsunenko et al., 2012; Aver-
shina et al., 2014). The lack of extensive bacterial competi-
tion results in high population levels in neonates,
exceeding the numbers found in adults (Stark and Lee,
1982). Facultative anaerobes utilize oxygen and thereby
create a reduced environment, making it more favorable
for subsequent colonization of strict anaerobe bacteria.
Therefore, the microbiota development continues in the
first weeks, with proliferation of strictly anaerobic bacteria
that are able to convert lactic acid derived from to the
milk-rich diet. Infants that are exclusively breast-fed in
general harbor a microbiota dominated by bifidobacteria,
while exclusively formula-fed infants harbor a more
diverse microbiota with increased abundance of Esche-
richia coli, Clostridia, and Bacteroides (Penders et al., 2006;
Fallani et al., 2010; Bezirtzoglou et al., 2011; Azad et al.,
2013a; Backhed et al., 2015). A recent study revealed by
deep sequencing that formula-fed infants displayed
enhanced populations of Ganulicatella, Citrobacter, Entero-
bacter, and Bilophila, whereas breast-fed infants showed
increased Lactobacillus species apart from bifidobacteria
(Backhed et al., 2015). The beneficial effects of human
milk oligosaccharides (HMOs), a structurally diverse family
of unconjugated glycans that are highly abundant in
human milk and absent in formula nutrition, might cause
the differences in the microbiota composition between
formula-fed and breast-fed infants. The maternal HMO’s
have a prebiotic role and promote the growth of Bifidobac-
terium, increase microbial diversity, and are able to protect
the infant against a number of enteropathogenic microor-
ganisms (Zivkovic et al., 2011). The quantity and composi-
tion of these oligosaccharides varies over the course of the
lactation period, but also between individual women,
mainly driven by their genotype (Bode, 2012; Cabrera-
Rubio et al., 2012).
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Additionally, breastmilk contains other immunologic
compounds, i.e., IgA, lactoferrin, and lysozyme (Pacheco
et al., 2015). All these factors are able to interact with
pathogens, reduce their viability, and prevent their attach-
ment to the intestinal mucosal surface, assisting the
expansion of commensal bacteria. Therefore, factors such
as the IgA repertoire might shape a distinct neonatal
microbiota (Rogier et al., 2014). Vitamin D, which is part
of infant formulas and a recommended supplement in
breastfed infants, is another compound that has been sug-
gested to influence the developing microbiome (Ly et al.,
2011), given its role in the development of regulatory T-
cells and dendritic cells (Griffin et al., 2003). Direct evi-
dence, however, is limited to a single study correlating a
lower vitamin D intake to a different microbiota composi-
tion in adult African Americans, as compared with Cauca-
sian Americans (Volker et al., 2009). The results need to
be confirmed in larger longitudinal studies.
Interestingly, recent studies also revealed the presence
of a microbiota in maternal breastmilk. With concentra-
tions of 102 to 104 viable bacterial per mL breast milk, an
exclusively breastfed infant will consume the significant
amount of about 105 to 107 commensal bacteria per day
(Heikkila and Saris, 2003). A study on variations in the
breastmilk microbiome over the course of lactation indi-
cated that staphylococci, streptococci, and lactobacilli
derived from the milk ducts and skin predominated in
colostrum, whereas after six months a higher abundance
of oral taxa, including Veillonella and Prevotella, were
found in breastmilk (Cabrera-Rubio et al., 2012). Other
studies hypothesize an entero-mammary pathway, postu-
lating that maternal gut bacteria could translocate through
the intestinal epithelial barrier, migrate to the mammary
gland, and subsequently become secreted with the milk
and colonize the breastfed neonate (Fernandez et al.,
2013). Using a combination of culture-dependent and -
independent methods, Jost et al. (2014) examined whether
viable strains of gut-associated obligate anaerobes were
shared between the maternal and neonatal gut microbiota
and transferred via breastfeeding. Next to facultative anae-
robes, obligate anaerobic genera, including Bifidobacte-
rium, Bacteroides, and Clostridia were detected in maternal
faeces, breast milk, and neonatal feces. Moreover, pulse-
field gel electrophoreses (PFGE) of Bifidobacterium breve
isolates from maternal feces, breast milk, and neonatal
feces of a single mother-child pair, revealed identical
restriction profiles, suggesting transfer of these strains
from the maternal to the neonatal gut via breast milk (Jost
et al., 2014). Alternatively, the maternal gut might repre-
sent a common source for both the mammary skin/gland
duct bacteria as well as the neonatal intestine.
The third stage in the development of the microbiota
is defined by alterations of the microbial composition and
function, due to the introduction of solid food 4 to 6
months postpartum (weaning). Upon weaning, the
microbiota functionally maturates by a decrease in the rel-
ative abundance of genes involved in the degradation of
sugars from breast milk and towards enrichment of genes
involved in the degradation of complex sugars and starch.
The major pectin-degrading enzyme, pectinesterase, has
been shown to be enriched in infants by the age of 12
months, likely in response to the increased intake of foods
rich in pectin by this age (Backhed et al., 2015). The par-
ticular effects of solid foods, however, strongly depend on
the geography linked to major differences in dietary habits
around the world. In western countries, the introduction
of a more complex diet rapidly increases the levels of Bac-
teroides and Clostridium, alters the lactobacilli commun-
ities, and decreases the Bifidobacterium levels (Yatsunenko
et al., 2012; Avershina et al., 2014; Bergstrom et al., 2014;
Backhed et al., 2015). The intestinal microbiota closely
resembles the diverse adult-like composition at the age of
three years (Yatsunenko et al., 2012; Bergstrom et al.,
2014), even though older data indicated that microbial sta-
bility is already achieved at the age of 1 year (Palmer
et al., 2007; Koenig et al., 2011). Interestingly, a longitudi-
nal study of 98 Swedish mothers and their infants also
compared the bacterial composition between the introduc-
tion of solid food with and without continuation of breast-
feeding (Backhed et al., 2015). This comparison suggested
that the cessation of breastfeeding, rather than the intro-
duction of solid food, represents the major factor driving
the microbiota composition towards a more adult-like
ecology. Altogether, these data emphasize the role of
breastmilk and diet in the succession and shaping of the
intestinal microbiota in early life.
ENVIRONMENTAL EXPOSURE
Besides the influence of the mother and the associated
exposures during delivery, the child’s living environment,
including the indoor home environment, pets, and older
siblings as sources for microbial exposure, has been shown
to affect the intestinal microbial development. A recent
longitudinal study by the Home Microbiome Consortium,
showed substantial interaction among the human, home,
and pet microbiota (Lax et al., 2014). Moreover, strikingly
similar dynamics in the development of the enteric micro-
biota of a fraternal twin pair, including the coincidental
transient appearance of specific organisms in both twins,
suggest that stochastic environmental influences can also
play an important role during the assembly of microbial
communities (Palmer et al., 2007).
Siblings. Singletons seem to have a distinct colonization
pattern in comparison with infants that grow up together
with older siblings, although data are scarce and not
always consistent. The Canadian Healthy Infant Longtudi-
nal Development (CHILD) cohort showed a lower abun-
dance of C. difficile and its family Peptostreptococcaceae
(Azad et al., 2013a), whereas a German study reported
decreased colonization rates of Clostridium cluster I in
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newborns with older siblings, as compared with singletons
(Penders et al., 2013). The higher levels of Clostridium
species in singletons are in accordance with another study
comprising three European birth cohorts (Adlerberth
et al., 2007). A decrease in bifidobacteria in infants with-
out older siblings has also been reported (Penders et al.,
2006). Moreover, a higher microbial richness and diversity
has recently been observed in infants with older siblings
(Laursen et al., 2015). Altogether, these data suggest that
firstborn infants harbor a less mature microbiota than
infants with older siblings at a certain age, which may
impact the risk on allergies (Penders et al., 2014).
Whether this occurs due to direct or indirect bacterial
transfer between siblings or due to other factors, such as
altered vaginal microbiota and breastmilk composition in
multiparous, as compared with primiparous women,
remains to be elucidated.
Pets and house dust. There is limited data available on the
role of in-house microbial exposure in humans, but an
association between the bacteria found in house dust and
in children has recently been reported (Konya et al.,
2014). Moreover, Azad et al. (2013b) observed that the
presence of pets might affect infant colonization, in con-
trast to studies that did not find a relation between the
presence of household pets and the human gut microbiota
(Penders et al., 2006; Konya et al., 2014). Pets might also
cause the occurrence of certain bacteria in house dust and
transfer of specific communities to humans. Infants living
with pets showed mainly increased Peptostrepococcaceae
(C. difficile) and decreased abundance of bifidobacteria at
4 months of age. The discrepancy between studies might
indicate the minor role of pets, and more research is nec-
essary to confirm the association and identify transfer
pathways.
Geography. The microbial ecology also differs between
infants from various geographical habitats. Children born
in developing countries are characterized by enhanced lev-
els of Prevotella and decreased abundance of Bacteroides
in early life, as compared with infants living in western
countries (De Filippo et al., 2010; Grzeskowiak et al.,
2012; Yatsunenko et al., 2012; Clemente et al., 2015). The
geographical variation in colonization patterns might
mainly result from differences in diet, as segregation of
the microbiota composition into distinct geographic clus-
ters becomes apparent only after weaning, i.e., the start of
consumption of solid food (De Filippo et al., 2010). The
food in developing countries is low in fat and protein, and
rich in fibers, compared with the typical western diet. In
addition, the advanced sanitary conditions in western
countries, compared with a less advanced infrastructure
and crowded settings in developmental countries, could
also influence differences in indigenous microbial commu-
nity structures. Furthermore, intra-continental differences
between western countries have also been reported with
lower proportions of Bifidobacterium and higher propor-
tions of Akkermansia, Clostridium, and Bacteroides in Ger-
man infants than Finish infants (Grzeskowiak et al., 2012).
The latter is in line with another European study that
showed overrepresentation of Bifidobacterium in Northern
European infants, whereas increased diversity was
detected in Southern European infants (Fallani et al.,
2010). However, whether these differences are driven by
environmental exposure, genetic make-up, or dietary fac-
tors is currently unclear.
HOST GENETICS
Host genotype is another factor with a major impact on
the microbial composition, as shown by studies comparing
the microbiota of individuals with varying degrees of relat-
edness, in particular monozygotic as compared with dizy-
gotic twins. Several studies using traditional microbial
fingerprinting techniques in both children and adults
reported host genetic effects on the microbiota composi-
tion (Van de Merwe et al., 1983; Zoetendal et al., 2001;
Stewart et al., 2005). A recent study analyzing the micro-
biota development by next-generation sequencing in three
dichorionic triplet sets showed that at the age of one
month the monozygotic twin pairs shared a more similar
microbiota, as compared with their fraternal siblings. By
month 12 however, the profile became more uniform
between the three infants, suggesting that host genetics
initially play a significant role, while environmental deter-
minants dominate by the age of 12 months (Murphy et al.,
2015).
By far the most comprehensive study to date examined
the influence of host genetics on the microbiota using fecal
samples of 416 pairs of adult twins from the TwinsUK
cohort (Goodrich et al., 2014). The microbiota were more
similar between twin pairs as compared with unrelated
individuals, and were also more similar between monozy-
gotic twins than dizygotic twins. By estimating the herit-
ability of individual microbial taxa, it was shown that the
community structure within the phylum Bacteroidetes was
mainly shaped by environmental factors. Heritability
appeared strongest for families within the phylum Firmi-
cutes, including Ruminococcaceae and Lachnospiraceae,
with Christensenellaceae being the most heritable family.
Christensenellaceae formed a co-occurrence network with
other microbes, such as methanogenic Archaea, and was
associated with lean BMI. The functional relevance was
illustrated by subsequent transfer of Christensenellaceae
species to germ-free mice resulting in reduced body
weight. Interestingly, the authors were able to validate
their findings of heritability of the above-mentioned bacte-
rial families by applying their statistical models to the
data of two studies that had previously failed to reveal sig-
nificant genotype effects on the microbiota (Turnbaugh
et al., 2009; Yatsunenko et al., 2012).
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Furthermore, studies using a candidate gene approach
examined the involvement of individual genes. For
instance, individuals that have a functional fucosyltransfer-
ase 2 (FUT2) gene, referred as secretors, displayed differ-
ent microbial communities compared with non-secretors
(Rausch et al., 2011). The secretor-status regulates the
existence of mucosal ABH and Lewis blood group antigens,
but also the glycosylation of the intestinal mucus and
breastmilk oligosaccharides. In addition, fucosyltransferase
3 (FUT3) produces the Lewis A antigens in nonsecretors
and B antigens in secretors. The profiles of the human
milk oligosaccharides have been shown to differ in accord-
ance to maternal secretor status, as well as Lewis blood
group antigen, due to genetic variations of FUT2 and
FUT3, respectively (Totten et al., 2012). In accordance, a
recent study observed earlier colonization and higher lev-
els of bifidobacteria in breastfed infants of maternal secre-
tors (Lewis et al., 2015). Many other candidate genes have
been suggested to influence microbiota composition.
Among them in particular are genes encoding immune
mediators, such as NOD2 and MEFV, reviewed in detail
elsewhere (Marietta et al., 2015). The nucleotide-binding
oligomerization domain 2 (NOD2) receptor recognizes bac-
terial cell wall-derived muramyl dipeptide fragments and
regulates the release of a-defensins by Paneth cells. Con-
sistent with an influence of enteric antimicrobial peptides
on microbiota composition (Salzman et al., 2010), expres-
sion of NOD2 has been shown to affect the microbial ecol-
ogy in mice (Petnicki-Ocwieja et al., 2009). In humans,
NOD2 mutations are a risk factor for the development of
inflammatory bowel disease and are associated with
microbial dysbiosis (Frank et al., 2011). Mutations in the
human gene MEFV that encodes pyrin result in familial
Mediterranean fever, an autoimmune disease with uncon-
trolled interleukin (IL)21 release. Mutations in MEFV are
associated with changes in the gut microbiota, including
lower bacterial diversity (Khachatryan et al., 2008). These
findings highlight that the genotype of the host influences
the intestinal microbiota composition, which in turn, may
influence host metabolism.
ANTIBIOTICS
Although the majority of common pediatric infections, e.g.,
upper respiratory tract infections, are self-limiting and
caused by viruses, large volumes of broad-spectrum antibi-
otics are still being prescribed for these conditions in pri-
mary care settings (Hersh et al., 2011), with little evidence
for clinical benefit (Smith et al., 2014). Next to being the
main factor driving the development and dissemination of
antimicrobial resistance, (over)use of antibiotics has pro-
found and direct effects on the indigenous microbiota. The
exact effects on the microbiota composition are dependent
on the specific type of antibiotic, but also differ between
individuals, as was demonstrated in a study on the
effects of ciprofloxacin treatment in healthy volunteers
(Dethlefsen et al., 2008). This latter study showed that the
microbiota is relatively resilient to perturbations induced
by a single course of antibiotics. A subsequent study, how-
ever, indicated that the microbiota composition may per-
manently shift to an alternative state, upon multiple
courses of ciprofloxacin (Dethlefsen and Relman, 2011). In
newborns exposed to antibiotics, obligate anaerobic gen-
era, such as Bacteroides spp. and Bifidobacterium spp. and
Lactobacillus spp., are depleted, whereas levels of Proteo-
bacteria increase (Penders et al., 2006; Savino et al., 2011;
Fouhy et al., 2012). Not surprisingly, maternal antibiotic
use during pregnancy or breastfeeding has also been
shown to affect the infant’s microbiota composition with
decreased levels of Bacteroides spp. and Atopbium spp.
(Fallani et al., 2010). Interestingly, the maternal vaginal
microbiota is affected by antibiotic use during pregnancy,
which might contribute to a distinct neonatal microbiome
(Stokholm et al., 2014).
To date, few studies have examined the effect of intra-
partum antibiotic prophylaxis (IAP), a practice routinely
used in pregnant women positive for group B streptococci
(GBS) on the vaginal mucosa, on the establishment of the
neonatal microbiome. GBS represents the most important
causative agent of neonatal sepsis with often fatal out-
come. In the absence of an available vaccine, prophylactic
antibiotic treatment represents the recommended measure
to prevent infection. Two recent studies, quantifying a
selected group of bacterial genera, revealed a decrease in
bifidobacterial abundance, as well as a shift in bifidobacte-
rial species composition, in newborns whose mothers did
receive IAP, as compared with newborns without maternal
IAP exposure (Aloisio et al., 2014; Corvaglia et al., in
press). In addition, newborns are (indirectly) exposed to
antibiotics during labor, as prophylaxes prior to C-section.
The effects on the neonatal microbiome have, however, not
been characterized.
Although there is little direct evidence from human
studies, it is highly likely that the developing infant micro-
biota is far less resilient to antibiotic-induced perturba-
tions than the microbiota of adults. This is supported by a
recent study mimicking pediatric antibiotic use in a
mouse-model by providing early-life administration of
antibiotics at therapeutic doses (b-lactam and macrolides).
Progressive and long-term alterations in the gut micro-
biota composition and metagenomic content were
observed, varying with the number of courses and class of
antibiotic treatment (Nobel et al., 2015). Moreover, murine
antibiotic exposure in early life showed an altered host
metabolism regarding energy harvesting and fat storage
(Cox et al., 2014; Nobel et al., 2015). Therefore, antibiotic
use during infancy has been suggested to increase subse-
quent weight gain and enhance the risk of childhood over-
weight (Ajslev et al., 2011; Trasande et al., 2013; Cox and
Blaser, 2015). The latter studies indicate that perturbation
of the microbiota in early life results in different metabolic
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effects even in the presence of a similar diet. The lack of
acquisition or the extinction of specific species during the
neonatal period might therefore represent a critical factor,
emphasizing the key role of pioneer bacteria.
WINDOW OF OPPORTUNITY FOR MICROBIOTA MANIPULATION
The therapeutic manipulation of the gut microbiota is
promising, since the microbiota plays a crucial role in
human health. For instance, fecal transplantation is a pro-
cedure that has recently raised a lot of scientific aware-
ness and many intervention studies are currently ongoing
to treat a variety of diseases. However, this method has so
far only been clinically accepted as an effective method to
eradicate C. difficile infection (Drekonja et al., 2015). More-
over, numerous randomized placebo-controlled trials have
been conducted on the efficacy of pre- and probiotic sup-
plementation in pregnant women and newborns in the pri-
mary prevention of diseases, such as necrotizing
enterocolitis (NEC), atopic diseases, and (extra)intestinal
infections. For most clinical outcomes the efficacy of pre-
and probiotic supplementation is inconclusive, although
there is evidence that probiotics might reduce the risk of
atopic eczema in infants (Cuello-Garcia et al., in press) and
NEC in preterm neonates (AlFaleh and Anabrees, 2014).
Yet, there is great heterogeneity between studies in terms
of the probiotic strains used, dosing, duration, and timing
of probiotic therapy. The understanding and selection of
the appropriate probiotics is crucial and should be deter-
mined by fundamental host-microbiota interactions.
Importantly, a better knowledge on the bacteria that are
essential for specific health effects might also stimulate
the use of selected diets or drugs as a way to modify the
microbiota. Further research is necessary to identify not
only beneficial bacteria, but also other microbes, such as
Archaea and viruses, and their interactions. This may
include approaches that use phage therapy as a tool
against specific bacteria or pathogens (Viertel et al., 2014).
In addition, a better understanding of ecological proc-
esses and pioneer consortia in microbial development will
be crucial to design efficacious therapies and standardized
manipulations. The microbial maturation relies on the suc-
cession of initial bacteria during infancy, making early life
a particular suitable period to modify the microbiota in
favor of health-promoting bacteria. The identification of
specific neonatal populations that will benefit most from
microbiota manipulation could also be relevant in terms of
personalized strategies, e.g., following C-section delivery,
intra-partum antibiotic prophylaxis or neonatal infections.
In this respect, trials are under way in which newborns
delivered via C-section are being exposed to the maternal
vaginal microbiota directly after birth. However, further
studies are needed to unravel the critical shaping factors
of intestinal bacteria in early life, in order to support
future targeted microbial therapies to reduce the risk of
disease.
CONCLUSION AND FUTURE PERSPECTIVES
Our knowledge on the maturation dynamics of the gut
microbiota during infancy has advanced considerably dur-
ing the past decades. The microbiota develops from the
initial inoculum to a complex and diverse ecosystem dur-
ing the first years of life and is influenced by a large
number of perinatal environmental and maternal factors
as summarized in Fig. 1. The colonization of essential bac-
teria in the neonatal gut is important, since their lack
might result in increased risk of metabolic or immune-
associated disorders, such as obesity or allergy, respec-
tively. The establishment of the microbiota and its func-
tion during early life is strongly affected by the mode of
delivery, breastmilk versus formula, and diet. Studies also
emphasize the destructive role of antibiotic exposure in
the succession of initial bacteria. In addition, the child’s
living location, including the indoor home environment,
the presence of pets and older siblings as sources for
microbial exposure, has been suggested to impact the
infant microbiota. Further studies highlighted the critical
role of the host’s genotype in the intestinal microbiota
composition, although these results were mostly derived
from animal studies. Importantly, besides the determi-
nants that select or shape the microbiota, the order of
acquiring specific bacteria—the historical contingency—
should also be taken into account. The historical contin-
gency might be crucial because it defines how bacteria
interact with each other and with the host, and may in
turn influence the entire community (Dethlefsen et al.,
2006). However, the order of microbial arrivals is mainly
stochastic and unknown, resulting in highly unpredictable
microbial interactions. Therefore, experimental studies
providing insight in the extent to which historical contin-
gency contributes to microbial assembly are pivotal.
Large-scale birth cohort studies generally assess the
growth or stability of the microbiome by sampling at
intervals ranging from months or years, but whether
these dynamics sufficiently reflect the variability over a
shorter period is unclear. As such, a regimen of more reg-
ular sampling moments (weekly or even daily) within the
context of longitudinal birth cohort studies is warranted.
Moreover, further research is needed to unravel the func-
tional and metabolic development of the neonatal micro-
biome. The integration of metatranscriptomics and
metabolomics in future longitudinal human studies will
greatly improve our understanding of the role of the
infant’s microbiome. It will also be crucial to determine
the impact of early microbial changes on the incidence
and severity of certain diseases in infancy as well as in
later life. Consequently, new longitudinal studies should
define in more detail the host-microbe interactions in
regard to infant’s health and provide sufficient follow-up
to monitor the onset of non-communicable diseases. For
instance, C-section may have a long-term impact on
child’s health, regarding immune-mediated disorders
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(Decker et al., 2010; Penders et al., 2014), as well as
increased BMI in offspring and obesity in adulthood (Dar-
masseelane et al., 2014). The latter emphasizes the crucial
role of the first inoculum, and suggests that the vaginal
microbiota has the ability to induce metabolic and
immune maturation in the newborn over a prolonged
time period. Insight into the multifaceted interactions
between the microbiota and ecological as well as host fac-
tors are still in its infancy, and need to be expanded to
facilitate therapeutic or prophylactic microbiota manipula-
tions. Altogether, the overall challenge will be to promote
certain bacterial populations in early life, prevent their
eradication by antibiotics, and in this way prevent the
development of non-communicable diseases.
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Emphasize Box
Data from human infants are commonly based on stool samples
which deviate considerably from colonic mucosal microbiota (Zoeten-
dal et al., 2002). Recent high-throughput microbial profiling also
showed that the mucosal microbiota even varies along the complete
length of the gut (Zhang et al., 2014). Therefore, data from animals
of small intestinal and colonic microbiota provides additional insight
on the development, as well as specific host-microbe interactions.
Although mice and rats have an increased exposure to environmental
and fecal microbiota, the essence of the initial succession of gut bac-
teria in rodents reflects that in humans. In mice, the neonatal gut is
mainly dominated by Lactobacillaceae, Streptococcus and Enterobac-
teriaceae (Pantoja-Feliciano et al., 2013; Del Chierico et al., 2014).
The colon in mice is first established by bacteria that resemble the
vaginal microbiota, followed by a decrease in microbial diversity and
shift in dominance from Streptococcus to Lactobacillus (Pantoja-
Feliciano et al., 2013). The microbial abundance seems to be related
to the anatomical complexity of the intestine, resulting in very low
FIGURE 1. Main maternal, environmental, and host determinants that impact the establishment of the intestinal microbiota during the first year of life. A non-
exclusive listing of bacterial taxa affected by these determinants is depicted at the bottom of the figure. Note: the timeline is colored ranging from white to blue
corresponding to a change in microbial diversity from low to high, respectively. Perinatal starts at rupture of the membranes.
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microbial diversity in a simple and small gut after birth (Del Chierico
et al., 2014). After the introduction of solid food, the murine micro-
biota increases in strictly anaerobes such as Bacteroides, Lachnospir-
aceae, and Clostridium. Altogether, animal studies further indicate
that the microbiota development is multiple-phasic and is pivotal in
unraveling host-microbiota relationships.
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